The status of MRI databases across the world focused on psychiatric and neurological disorders.
MRI
data sharing
database
neurological disorders
psychiatric disorders
Journal
Psychiatry and clinical neurosciences
ISSN: 1440-1819
Titre abrégé: Psychiatry Clin Neurosci
Pays: Australia
ID NLM: 9513551
Informations de publication
Date de publication:
20 Aug 2024
20 Aug 2024
Historique:
revised:
13
05
2024
received:
22
01
2024
accepted:
02
07
2024
medline:
20
8
2024
pubmed:
20
8
2024
entrez:
20
8
2024
Statut:
aheadofprint
Résumé
Neuroimaging databases for neuro-psychiatric disorders enable researchers to implement data-driven research approaches by providing access to rich data that can be used to study disease, build and validate machine learning models, and even redefine disease spectra. The importance of sharing large, multi-center, multi-disorder databases has gradually been recognized in order to truly translate brain imaging knowledge into real-world clinical practice. Here, we review MRI databases that share data globally to serve multiple psychiatric or neurological disorders. We found 42 datasets consisting of 23,293 samples from patients with psychiatry and neurological disorders and healthy controls; 1245 samples from mood disorders (major depressive disorder and bipolar disorder), 2015 samples from developmental disorders (autism spectrum disorder, attention-deficit hyperactivity disorder), 675 samples from schizophrenia, 1194 samples from Parkinson's disease, 5865 samples from dementia (including Alzheimer's disease), We recognize that large, multi-center databases should include governance processes that allow data to be shared across national boundaries. Addressing technical and regulatory issues of existing databases can lead to better design and implementation and improve data access for the research community. The current trend toward the development of shareable MRI databases will contribute to a better understanding of the pathophysiology, diagnosis and assessment, and development of early interventions for neuropsychiatric disorders.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Japan Agency for Medical Research and Development
ID : JP18dm0307001
Organisme : Japan Agency for Medical Research and Development
ID : JP18dm0307002
Organisme : Japan Agency for Medical Research and Development
ID : JP18dm0307003
Organisme : Japan Agency for Medical Research and Development
ID : JP18dm0307004
Organisme : Japan Agency for Medical Research and Development
ID : JP18dm0307008
Organisme : Japan Agency for Medical Research and Development
ID : JP18dm0307009
Organisme : Japan Agency for Medical Research and Development
ID : JP19dm0307101
Organisme : Japan Agency for Medical Research and Development
ID : JP19dm0307102
Organisme : Japan Agency for Medical Research and Development
ID : JP19dm0307103
Organisme : Japan Agency for Medical Research and Development
ID : JP19dm0307104
Organisme : Japan Agency for Medical Research and Development
ID : JP19dm0307105
Organisme : Japan Agency for Medical Research and Development
ID : JP23wm0625001
Organisme : Acquisition, Technology & Logistics Agency
ID : JPJ004596
Informations de copyright
© 2024 The Author(s). Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.
Références
Diagnostic and statistical manual of mental disorders: DSM‐5™, 5th edn. American Psychiatric Publishing, Inc, Arlington, VA, US, 2013.
Cuthbert BN. Research domain criteria: Toward future psychiatric nosologies. Dialogues Clin. Neurosci. 2015; 17: 89–97.
Insel TR, Cuthbert BN. Brain disorders? Precisely. Science 2015; 348: 499–500.
Cross‐Disorder Group of the Psychiatric Genomics, C, Lee SH, Ripke S et al. Genetic relationship between five psychiatric disorders estimated from genome‐wide SNPs. Nat. Genet. 2013; 45: 984–994.
Goodkind M, Eickhoff SB, Oathes DJ et al. Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry 2015; 72: 305–315.
Jacobi F, Wittchen HU, Holting C et al. Prevalence, co‐morbidity and correlates of mental disorders in the general population: Results from the German health interview and examination survey (GHS). Psychol. Med. 2004; 34: 597–611.
McTeague LM, Huemer J, Carreon DM, Jiang Y, Eickhoff SB, Etkin A. Identification of common neural circuit disruptions in cognitive control across psychiatric disorders. Am. J. Psychiatry 2017; 174: 676–685.
Beijers L, Wardenaar KJ, vanLoo HM, Schoevers RA. Data‐driven biological subtypes of depression: Systematic review of biological approaches to depression subtyping. Mol. Psychiatry 2019; 24: 888–900.
Parkes L, Satterthwaite TD, Bassett DS. Towards precise resting‐state fMRI biomarkers in psychiatry: Synthesizing developments in transdiagnostic research, dimensional models of psychopathology, and normative neurodevelopment. Curr. Opin. Neurobiol. 2020; 65: 120–128.
Xia M, He Y. Functional connectomics from a "big data" perspective. Neuroimage 2017; 160: 152–167.
Yassin W, Nakatani H, Zhu Y et al. Machine‐learning classification using neuroimaging data in schizophrenia, autism, ultra‐high risk and first‐episode psychosis. Transl. Psychiatry 2020; 10: 278.
Zhang X, Braun U, Tost H, Bassett DS. Data‐driven approaches to neuroimaging analysis to enhance psychiatric diagnosis and therapy. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 2020; 5: 780–790.
Zhu Y, Nakatani H, Yassin W et al. Application of a machine learning algorithm for structural Brain images in chronic schizophrenia to earlier clinical stages of psychosis and autism Spectrum disorder: A multiprotocol imaging dataset study. Schizophr. Bull. 2022; sbac030: 563–574.
Drysdale AT, Grosenick L, Downar J et al. Resting‐state connectivity biomarkers define neurophysiological subtypes of depression. Nat. Med. 2017; 23: 28–38.
Ichikawa N, Lisi G, Yahata N et al. Primary functional brain connections associated with melancholic major depressive disorder and modulation by antidepressants. Sci. Rep. 2020; 10: 3542.
Takagi Y, Sakai Y, Lisi G et al. A neural marker of obsessive‐compulsive disorder from whole‐Brain functional connectivity. Sci. Rep. 2017; 7: 7538.
Yoshihara Y, Lisi G, Yahata N et al. Overlapping but asymmetrical relationships between schizophrenia and autism revealed by Brain connectivity. Schizophr. Bull. 2020; 46: 1210–1218.
Chang M, Womer FY, Gong X et al. Identifying and validating subtypes within major psychiatric disorders based on frontal‐posterior functional imbalance via deep learning. Mol. Psychiatry 2021; 26: 2991–3002.
Clementz BA, Sweeney JA, Hamm JP et al. Identification of distinct psychosis biotypes using Brain‐based biomarkers. Am. J. Psychiatry 2016; 173: 373–384.
Togo H, Nakamura T, Wakasugi N, Takahashi Y, Hanakawa T. Interactions across emotional, cognitive and subcortical motor networks underlying freezing of gait. NeuroImage: Clin. 2023; 37: 103342.
Tokuda T, Yamashita O, Sakai Y, Yoshimoto J. Clustering of multiple psychiatric disorders using functional connectivity in the data‐driven Brain subnetwork. Front. Psychiatry 2021; 12: 683280. https://doi.org/10.3389/fpsyt.2021.683280.
Tokuda T, Yoshimoto J, Shimizu Y et al. Identification of depression subtypes and relevant brain regions using a data‐driven approach. Sci. Rep. 2018; 8: 14082.
Ma Q, Tang Y, Wang F et al. Transdiagnostic dysfunctions in Brain modules across patients with schizophrenia, bipolar disorder, and major depressive disorder: A connectome‐based study. Schizophr. Bull. 2020; 46: 699–712.
Xia CH, Ma Z, Ciric R et al. Linked dimensions of psychopathology and connectivity in functional brain networks. Nat. Commun. 2018; 9: 3003.
Marek S, Tervo‐Clemmens B, Calabro FJ et al. Reproducible brain‐wide association studies require thousands of individuals. Nature 2022; 603: 654–660.
Dinga R, Schmaal L, Penninx B et al. Evaluating the evidence for biotypes of depression: Methodological replication and extension of. Neuroimage Clin. 2019; 22: 101796.
Whelan R, Garavan H. When optimism hurts: Inflated predictions in psychiatric neuroimaging. Biol. Psychiatry 2014; 75: 746–748.
Winter NR, Hahn T. Significance and stability of deep learning‐based identification of subtypes within major psychiatric disorders. Mol. Psychiatry 2022; 27: 1858–1859.
Woo CW, Chang LJ, Lindquist MA, Wager TD. Building better biomarkers: Brain models in translational neuroimaging. Nat. Neurosci. 2017; 20: 365–377.
Lucas‐Dominguez R, Alonso‐Arroyo A, Vidal‐Infer A, Aleixandre‐Benavent R. The sharing of research data facing the COVID‐19 pandemic. Scientometrics 2021; 126: 4975–4990.
Eke DO, Bernard A, Bjaalie JG et al. International data governance for neuroscience. Neuron 2022; 110: 600–612.
Smith SM, Nichols TE. Statistical challenges in "big data" human neuroimaging. Neuron 2018; 97: 263–268.
Yamashita A, Yahata N, Itahashi T et al. Harmonization of resting‐state functional MRI data across multiple imaging sites via the separation of site differences into sampling bias and measurement bias. PLoS Biol. 2019; 17: e3000042.
Cetin Karayumak S, Bouix S, Ning L et al. Retrospective harmonization of multi‐site diffusion MRI data acquired with different acquisition parameters. Neuroimage 2019; 184: 180–200.
Chen AA, Beer JC, Tustison NJ et al. Mitigating site effects in covariance for machine learning in neuroimaging data. Hum. Brain Mapp. 2022; 43: 1179–1195.
Chen AA, Srinivasan D, Pomponio R et al. Harmonizing functional connectivity reduces scanner effects in community detection. Neuroimage, 2022; 256: 119198.
Maikusa N, Zhu Y, Uematsu A et al. Comparison of traveling‐subject and ComBat harmonization methods for assessing structural brain characteristics. Hum. Brain Mapp. 2021; 42: 5278–5287.
Moyer D, Ver Steeg G, Tax CMW, Thompson PM. Scanner invariant representations for diffusion MRI harmonization. Magn. Reson. Med. 2020; 84: 2174–2189.
Ning L, Bonet‐Carne E, Grussu F et al. Cross‐scanner and cross‐protocol multi‐shell diffusion MRI data harmonization: Algorithms and results. Neuroimage 2020; 221: 117128.
Pinto MS, Paolella R, Billiet T et al. Harmonization of Brain diffusion MRI: Concepts and methods. Front. Neurosci. 2020; 14: 396.
Pomponio R, Erus G, Habes M et al. Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan. Neuroimage 2020; 208: 116450.
Reardon AM, Li K, Hu XP. Improving between‐group effect size for multi‐site functional connectivity data via site‐wise De‐meaning. Front. Comput. Neurosci. 2021; 15: 762781.
Tian D, Zeng Z, Sun X et al. A deep learning‐based multisite neuroimage harmonization framework established with traveling‐subject dataset. Neuroimage 2022; 257: 119297.
Koike S, Tanaka SC, Okada T et al. Brain/MINDS beyond human brain MRI project: A protocol for multi‐level harmonization across brain disorders throughout the lifespan. Neuroimage Clin. 2021; 30: 102600.
Yamashita A, Sakai Y, Yamada T et al. Generalizable brain network markers of major depressive disorder across multiple imaging sites. PLoS Biol. 2020; 18: e3000966.
Tanaka SC, Yamashita A, Yahata N et al. A multi‐site, multi‐disorder resting‐state magnetic resonance image database. Sci. Data 2021; 8: 227.
Alexander L, Escalera J, Ai L et al. An open resource for transdiagnostic research in pediatric mental health and learning disorders. Sci Data 2017; 4: 170181.
Gorgolewski KJ, Auer T, Calhoun VD et al. The brain imaging data structure, a format for organizing and describing outputs of neuroimaging experiments. Sci. Data 2016; 3: 160044.
Poldrack RA, Markiewicz CJ, Appelhoff S et al. The past, present, and future of the brain imaging data structure (BIDS). Imaging Neurosci. 2024; 2: 1–19.
Hayashi S, Caron BA, Heinsfeld AS et al. Brainlife.Io: A decentralized and open‐source cloud platform to support neuroscience research. Nat. Methods 2024; 21: 809–813.
Queder N, Tien VB, Abraham SA et al. NIDM‐terms: Community‐based terminology management for improved neuroimaging dataset descriptions and query. Front. Neuroinform. 2023; 17: 1174156.
Bethlehem RAI, Seidlitz J, White SR et al. Brain charts for the human lifespan. Nature 2022; 604: 525–533.
Cheon EJ, Bearden CE, Sun D et al. Cross disorder comparisons of brain structure in schizophrenia, bipolar disorder, major depressive disorder, and 22q11.2 deletion syndrome: A review of ENIGMA findings. Psychiatry Clin. Neurosci. 2022; 76: 140–161.
Hibar DP, Westlye LT, Doan NT et al. Cortical abnormalities in bipolar disorder: An MRI analysis of 6503 individuals from the ENIGMA bipolar disorder working group. Mol. Psychiatry 2018; 23: 932–942.
Schmaal L, Hibar DP, Sämann PG et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA major depressive disorder working group. Mol. Psychiatry 2017; 22: 900–909.
Schmaal L, Veltman DJ, Van Erp TGM et al. Subcortical brain alterations in major depressive disorder: Findings from the ENIGMA major depressive disorder working group. Mol. Psychiatry 2016; 21: 806–812.
Van Erp TGM, Hibar DP, Rasmussen JM et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol. Psychiatry 2016; 21: 547–553.
Okada N, Fukunaga M, Yamashita F et al. Abnormal asymmetries in subcortical brain volume in schizophrenia. Mol. Psychiatry 2016; 21: 1460–1466.
Wakasugi N, Hanakawa T. It is time to study overlapping molecular and circuit Pathophysiologies in Alzheimer's and Lewy body disease spectra. Front. Syst. Neurosci. 2021; 15: 777706.
Hamatani S, Hirano Y, Sugawara A et al. Eating disorder neuroimaging initiative (EDNI): A multicentre prospective cohort study protocol for elucidating the neural effects of cognitive‐behavioural therapy for eating disorders. BMJ Open 2021; 11: e042685.